Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

bioAffinity Technologies, Inc. (BIAF) vs Psychemedics Corporation (PMD)

bioAffinity Technologies, Inc. and Psychemedics Corporation are both Diagnostics & Research companies. Psychemedics Corporation is the larger, with a market value of $15.7M against $9.0M — 1.7× the size. Psychemedics Corporation grew revenue faster over the last twelve months: −10.9% against −23.2%. Psychemedics Corporation has the higher net margin (−9.45% vs −257.3%) and the higher return on invested capital (−31.4% vs −408.7%). Across the 17 metrics below, Psychemedics Corporation leads on 13 and bioAffinity Technologies, Inc. on 4.

Valuation

Metric BIAF PMD Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.47 0.80 4.87
P/B 0.73 3.05 3.12
Price to free cash flow n/m 19.46 34.02
EV/EBITDA n/m 77.29 25.20
EV/Sales 0.15 0.74 5.66
Earnings yield (1,380.14%) (11.99%) (1.75%)
Free cash flow yield (418.18%) 5.14% (0.13%)

Profitability

Metric BIAF PMD Diagnostics & Research median
Gross margin 34.61% 36.07% 50.89%
Operating margin (209.82%) (9.62%) (8.57%)
Net margin (257.33%) (9.45%) (6.37%)
Free cash flow margin (195.90%) 4.02% 0.00%
Return on equity (1,860.15%) (31.54%) (2.92%)
Return on assets (245.51%) (18.03%) (6.71%)
Return on invested capital (408.67%) (31.42%) 0.00%

Growth

Metric BIAF PMD Diagnostics & Research median
Revenue growth (TTM) (23.18%) (10.92%) 7.69%
EPS growth (last fiscal year) 61.55% 55.56% —
Revenue growth, 5-year CAGR — (12.18%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF PMD Diagnostics & Research median
Debt to equity 0.15 0.01 0.11
Current ratio 1.44 1.82 2.02
Net debt to EBITDA 0.57 (7.26) 0.78

Dividend

Metric BIAF PMD Diagnostics & Research median
Dividend yield — 4.79% 0.70%
Payout ratio — 0.00 0.00

Size

Metric BIAF PMD Diagnostics & Research median
Market cap 9.00m 15.70m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack